Join Dr. Pallavi Latthe, Consultant Gynaecologist and accredited subspecialist in Urogynaecology, for an informative session exploring the relationship between vulvovaginal atrophy, hormonal changes, and bladder health. This webinar will provide healthcare professionals with insights into the effects of hormonal fluctuations on the urinary system and discuss evidence-based treatments, including the use of the E-string vaginal oestrogen ring.

Session Highlights:

Understanding Vulvovaginal Atrophy: Examine the physiological changes associated with vulvovaginal atrophy and its impact on bladder function and urinary symptoms.
Hormonal Influences on Bladder Health: Explore how hormonal changes, particularly oestrogen deficiency, affect the lower urinary tract and contribute to conditions such as urinary incontinence and recurrent urinary tract infections.
Therapeutic Approaches: Discuss the role of local oestrogen therapy in managing symptoms, with a focus on the E-string vaginal oestrogen ring, its application, benefits, and considerations.

Learning Objectives:

By the end of this webinar, you will be able to:

Understand the physiological effects of vulvovaginal atrophy on bladder health, including common symptoms such as urinary incontinence and recurrent UTIs.
Gain knowledge of hormonal therapies, including the E-string vaginal oestrogen ring, and how they can be used to alleviate symptoms of vulvovaginal atrophy and support bladder health.
Learn practical strategies for integrating hormonal treatments into urology care, including how to counsel patients on their use and manage any associated concerns.
Develop confidence in identifying vulvovaginal atrophy as part of a holistic approach to managing urological conditions in postmenopausal patients.
Improve patient communication skills, ensure your patients understand the connection between hormonal changes, bladder health, and available treatment options.